Your session is about to expire
← Back to Search
OLZ/SAM for Schizophrenia
Study Summary
This trial looks at the safety and tolerability of a drug called OLZ/SAM in children with schizophrenia or bipolar I disorder.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- It is determined by the doctor that you will benefit from continuing treatment with OLZ/SAM medication.I am not on medications that can't be taken with olanzapine.I can receive treatment without staying in the hospital.
- Group 1: All subjects
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the requirements to participate in this research project?
"To be eligible for this research, participants must have a diagnosis of schizophrenia and be aged between 10 and 17 years old. Up to 236 patients will be enrolled in this clinical trial."
Is this study only meant for elderly patients?
"This upcoming clinical trial is only open to patients aged 10 to 17. Out of the 230 total trials, this is the 49th one specifically for those under 18 and the 181st for patients over 65."
Are there any available openings for new participants in this experiment?
"The clinical trial in question, which was last updated on February 9th, 2022, is not presently looking for candidates. However, there are 357 other trials that are."
Has the FDA cleared OLZ/SAM for therapeutic use?
"Based on our team's estimation, OLZ/SAM falls on the safe side of things because it is a Phase 3 trial. This means that, while there is some data supporting its efficacy, there is also multiple rounds of data supporting its safety."
Share this study with friends
Copy Link
Messenger